Literature DB >> 20463594

Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.

Maria Kosmidis1, Piotr Dziunycz, Mayte Suárez-Fariñas, Beda Mühleisen, Leo Schärer, Severin Läuchli, Jürg Hafner, Lars E French, Carsten Schmidt-Weber, John A Carucci, Günther F L Hofbauer.   

Abstract

Squamous cell carcinoma (SCC) is the most frequent cancer in organ transplant recipients (OTRs). The immune system plays a major role in the fight against SCC, however, little is known about the local inflammatory response in SCC at all. We analyzed quantity and quality of the perineoplastic inflammatory SCC microenvironment in immunocompetent patients and immmunosuppressed OTRs. RNA expression profile of SCC patients was analyzed for 8 different sets of genes relating to Th1 versus Th2 response using Gene Set Enrichment Analysis. SCC from immunocompetent patients and OTRs were analyzed by real-time polymerase chain reactions for CD4, CD8, TBET, GATA-3, FOXP3, RORC, IFN-gamma, IL-4, TGF-beta, IL-10, and IL-17A mRNA expression. Immunohistochemistry was carried out in SCC for CD3, CD4, CD8, and FOXP3 expression. Considerable inflammation was seen in both patient groups. SCC in immunocompetent patients and OTRs was associated with a mixed Th1 and Th2 gene expression signature. CD4(+) mRNA was diminished in immunosuppression. Skin adjacent to SCC in OTRs showed Th2 expression pattern as compared with immunocompetent patients. T-BET and IFN-gamma mRNA expression were decreased in the OTR group. Although Th17-weighted inflammation was unchanged, IL-17A mRNA level was markedly decreased with immunosuppression. Regulatory T cells, characterized by FOX-P3 and TGF-beta mRNA level, were decreased in OTRs. Our findings support the hypothesis that nontumor-bearing skin adjacent to SCC in OTRs is not necessarily normal and that the local microenvironment may contribute to a field effect contributing to higher recurrence rates and more aggressive behavior observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463594     DOI: 10.1097/CJI.0b013e3181cc2615

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  13 in total

Review 1.  Roles of the immune system in skin cancer.

Authors:  S Rangwala; K Y Tsai
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

2.  The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A.

Authors:  Piotr J Dziunycz; Karine Lefort; Xunwei Wu; Sandra N Freiberger; Johannes Neu; Nadia Djerbi; Guergana Iotzowa-Weiss; Lars E French; Gian-Paolo Dotto; Günther F L Hofbauer
Journal:  J Invest Dermatol       Date:  2014-02-07       Impact factor: 8.551

Review 3.  Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.

Authors:  Alexis L Santana; Diane Felsen; John A Carucci
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

4.  Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib.

Authors:  Álvaro March-Rodriguez; Beatriz Bellosillo; Alberto Álvarez-Larrán; Carles Besses; Ramon M Pujol; Agustí Toll
Journal:  Ann Dermatol       Date:  2019-02-28       Impact factor: 1.444

5.  Differential roles of T-cell subsets in regulation of ultraviolet radiation induced cutaneous photocarcinogenesis.

Authors:  Tahseen H Nasti; Omer Iqbal; Iman A Tamimi; James T Geise; Santosh K Katiyar; Nabiha Yusuf
Journal:  Photochem Photobiol       Date:  2010-12-08       Impact factor: 3.421

Review 6.  Calcineurin signaling as a negative determinant of keratinocyte cancer stem cell potential and carcinogenesis.

Authors:  G Paolo Dotto
Journal:  Cancer Res       Date:  2011-03-15       Impact factor: 12.701

Review 7.  Cutaneous Squamous Cell Carcinoma Arising in Immunosuppressed Patients: A Systematic Review of Tumor Profiling Studies.

Authors:  Elliot D Blue; S Caleb Freeman; Marissa B Lobl; Dillon D Clarey; Rose L Fredrick; Ashley Wysong; Melodi Javid Whitley
Journal:  JID Innov       Date:  2022-03-30

8.  S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.

Authors:  Guergana Iotzova-Weiss; Piotr J Dziunycz; Sandra N Freiberger; Severin Läuchli; Jürg Hafner; Thomas Vogl; Lars E French; Günther F L Hofbauer
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 9.  Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?

Authors:  J Morscio; D Dierickx; T Tousseyn
Journal:  Clin Dev Immunol       Date:  2013-04-14

Review 10.  Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy.

Authors:  Valerie R Yanofsky; Hiroshi Mitsui; Diane Felsen; John A Carucci
Journal:  Clin Dev Immunol       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.